Company Overview of Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. is a biopharmaceutical company that develops products for dermatology markets. Its products include V-101 is a prescription topical formulation for the treatment of the erythema of rosacea; V-102, an actinic purpura solution; and V-103, a peri-procedural bruising solution. The company also engages in the development of topical agents for the treatment and prevention of various medical and cosmetic indications, including bruising of the skin. The company was founded in 2009 and is based in Malvern, Pennsylvania. As of July 22, 2011, Vicept Therapeutics, Inc. operates as a subsidiary of Allergan Inc.
101 Lindenwood Drive
Malvern, PA 19355
Founded in 2009
Key Executives for Vicept Therapeutics, Inc.
Similar Private Companies By Industry
|MediNatura Inc.||United States|
|Araxes Pharma, LLC||United States|
|Dental Technologies, Inc.||United States|
|Premier Micronutrient Corporation||United States|
|McNeil Consumer Pharmaceuticals Co||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Vicept Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.